With Creatio's powerful low-code/no-code tools, both business and IT teams can automate operational and CRM workflows
BOSTON, Oct. 1, 2021 /PRNewswire-PRWeb/ — Creatio, a global software company that provides a leading no-code/low-code platform for process management and CRM, today announced it has been recognized in the September 2021 Gartner Magic Quadrant for Enterprise Low-Code Application Platforms (1).
The report evaluates 12 LCAP vendors, out of the hundreds that market their products as LCAPs, based on their Ability to Execute and Completeness of Vision. According to Gartner®, "Organizations are increasingly adopting LCAPs to enable fusion team development with IT and business to quickly deliver new solutions and modernize business capabilities." In their research they predict that "By 2025, 70% of new applications developed by enterprises will use low-code or no-code technologies, up from less than 25% in 2020."
Creatio believes this recognition is thanks to enterprise-ready flexible low-code capabilities that empower businesses from various industries to automate workflows faster than ever. With Creatio's powerful low-code/no-code tools both business and IT teams can automate operational and CRM workflows of any complexity and gain the freedom to own their automation.
"Low-code and no-code application development has become a real game-changer for many organizations worldwide. We are happy to see that the market matures, and we are inspired by how our customers leverage Creatio low-code platform to automate enterprise-grade workflows across thousands of use cases without touching the code," said Katherine Kostereva, CEO and Founder of Creatio. "It's an honor for us to be recognized by Gartner in their 2021 Magic Quadrant for Enterprise Low Code Application Platforms," she added.
Try Studio Creatio for free >>
(1) Gartner, Magic Quadrant for Enterprise Low-Code Application Platforms, Jason Wong, Kimihiko Iijima, Adrian Leow, Akash Jain, Paul Vincent, 20 September 2021. GARTNER and MAGIC QUADRANT are a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission
Disclaimer: Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Creatio
Creatio is a global software company providing a leading no-code/low-code platform for process management and CRM.
The company has been highly recognized as a market leader by key industry analysts. Its intelligent products accelerate sales, marketing, service and operations for mid-size and large enterprises. Together with hundreds of partners Creatio operates in 110 countries worldwide.
For more information, please visit http://www.creatio.com

Media Contact
Peter Moran, Indicate Media, (347) 880-2895, peter@indicatemedia.com
SOURCE Creatio
Shares of Merck & Co. (NYSE: MRK) were trading 5.5% lower as of 12:46 p.m. ET on Monday. The decline came after Citi analyst Andrew Baum downgraded the stock from buy to neutral, and lowered his 12-month price target on it from $105 to $85. In this case, Baum's downgrade decision was driven by a pair of significant disappointments that Merck reported in recent weeks.
— in which its stock shed 3.6%, shares of semiconductors star Nvidia (NASDAQ: NVDA) are bouncing back Monday morning, up 2.8% as of 11 a.m. ET. The reason: I suspect investors are shrugging off last week's bad coronavirus news and focusing on some good Nvidia news that got overlooked. Specifically, I mean the news that on Friday analysts at investment bank Bank of America doubled down on their buy rating on Nvidia stock.
After sliding along with the rest of the stock market on Friday, shares of lithium mining stock Lithium Americas (NYSE: LAC) are rebounding in a big way on Monday — up 13.6% as of 12:15 p.m. ET. You can thank the friendly analysts at National Bank Financial for that. No sooner had Lithium Americas finished its Friday slide than an analyst at the Canadian investment bank stepped in and reiterated an outperform recommendation on the stock.
Wall Street has known its share of legends, but few of them have made as big a splash as “the Man Who Broke the Bank of England.” That nickname belongs to George Soros who earned the tag after famously betting against the British Pound in 1992; following the Black Wednesday crash, the hedge fund manager pocketed a $1 billion in a single day. This is the stuff that Wall Street legends are made of. By then Soros was already incredibly successful and in the midst of steering his Quantum Fund to dec
Shares of Krystal were up 120% in Monday trading on the company's report of initial data from the pivotal trial of its Vyjuvek treatment.
The technology powering virtual reality (VR) experiences has significantly improved in recent years. This technology is powering real-world applications like virtual walkthroughs of buildings and products still on the drawing board, or collaborations with colleagues in a virtual meeting room. Facebook has made a big splash into this new "metaverse" by changing its name to Meta Platforms (NASDAQ: FB), but that's not the only way to play this trend as an investor.
Words have power — as investors discovered to their dismay last week. News of the new omicron variant of COVID-19 shocked the stock market, sending shares of cruise line stocks Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL) (NYSE: CUK), and Norwegian Cruise Line Holdings (NYSE: NCLH) tumbling 10% and more in Friday trading.
Microsoft (NASDAQ: MSFT) recently became a hot topic after CEO Satya Nadella sold more than half of his shares for about $285 million on Nov. 22 and 23. When Nadella took over as Microsoft's third CEO in 2014, the tech giant was in serious trouble. Microsoft's cloud business became its core growth engine, and the company's revenue surged from $86.8 billion in fiscal 2014 to $168.1 billion in fiscal 2021, which ended this June, as its earnings per share more than tripled.
Electric vehicle stocks are back to trading more on the progress in their business, and less on splashy IPO hype.
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.
In this daily bar chart of CRWD, below, we can see that prices have declined this month to break below the cresting 200-day moving average line. The On-Balance-Volume (OBV) line has been weak the past three months as sellers of CRWD have been more aggressive. In this weekly Japanese candlestick chart of CRWD, below, we see a mixed picture.
These stocks could still provide amazing returns for the next decade, despite their already-impressive growth.
Shares of Tesla (NASDAQ: TSLA) rose sharply on Monday. The growth stock's sharp gain was likely due to reports over the weekend that Tesla is set to begin production at its new factory in Germany by next month. On an overall bullish Monday for stocks, the S&P 500 was up nearly 1% as of this writing, and the Nasdaq Composite was up about 1.3%.
A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
Yahoo Finance's Ines Ferre provides an update on Merck, Tesla, and Avis.
Although it's been a dud of a performer in 2021, telehealth platform Teladoc Health (NYSE: TDOC) is a holding I fully expect to deliver 10X (or greater) returns by the time I'm ready to enjoy retirement. While some folks would opine that Teladoc was lucky to be in the right place at the right time when the pandemic struck, I'd contend that they're not looking at the bigger picture. For instance, in the six years leading up to the pandemic, Teladoc's average annual sales grew by 74%.
Paysafe Limited ( NYSE:PSFE ) is possibly approaching a major achievement in its business, so we would like to shine…
(Reuters) -Three U.S. House Democrats on Monday asked the head of the Federal Aviation Administration (FAA) to provide more details of the agency's oversight of Boeing's 737 MAX and questioned whether the planemaker had been held fully accountable. The lawmakers, including House Transportation and Infrastructure chairman Peter DeFazio, asked FAA Administrator Steve Dickson in a letter Monday what the agency had done, if anything to hold Boeing employees responsible for various transgressions. The letter said these included Boeing's apparent violation of its approved 737 MAX type design, as well as evidence of an internal plan to downplay the significance of a key safety system called MCAS tied to both fatal crashes.
Capital gains taxes on real estate and property can be reduced when you sell your home, up to certain tax limits, if you meet the requirements.
In this piece, we will take a look at 10 biotech and pharma stocks to buy according to billionaire Steve Cohen. If you want to skip ahead to the top five stocks in this list, then head over to 5 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen. Steve Cohen is an […]

source

Leave a Reply